Diazenyl: The Potent Pharmacophore for Cancer Chemotherapy - Sarangi, Priyambada
51,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
26 °P sammeln
  • Broschiertes Buch

Cancer is denoted as one of the world's most deadly diseases and highest killer of the world's population. Though there is various treatment options such as surgery, radiation therapy, chemotherapy, immunotherapy are available for treatment of cancer but chemotherapy remains the most convenient and widely adaptable therapeutic option among them. But drug resistance is a serious issue of it. Hence development of new drug is always a necessity especially when drug resistance is a serious concern in cancer therapy. Many nitrogen bearing heterocyclic molecules have been proved to be potential…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Cancer is denoted as one of the world's most deadly diseases and highest killer of the world's population. Though there is various treatment options such as surgery, radiation therapy, chemotherapy, immunotherapy are available for treatment of cancer but chemotherapy remains the most convenient and widely adaptable therapeutic option among them. But drug resistance is a serious issue of it. Hence development of new drug is always a necessity especially when drug resistance is a serious concern in cancer therapy. Many nitrogen bearing heterocyclic molecules have been proved to be potential therapeutic agents with versatile biological activities. Moreover the nitrogeneous heterocyclic molecules with quinoline and thiazole nucleus have already been in use in the treatment of different types of cancer. At present not only the currently marketed pharmaceuticals but also so many other molecules under investigation containing diazenyl synthon are showing potent cytotoxic activity. In tothe light of biomedical importance the present study highlights the design and development of quinoline and thiazole containing azo molecules with special emphasis on advancement of cancer chemotherapy.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Priyambada Sarangi, a native of Bhubaneswar, Odisha, India holds her graduation in Pharmacy, Post graduation in Pharmaceutical Chemistry and Ph.D in Pharmacy. She started her career as a lecturer and has more than 14 years of academic/administrative experience. Presently she is a faculty member in GITAM School of Pharmacy.